龙沙集团持续利用生物制药优化趋势(场外交易代码:LZAGY)——Seeking Alpha
Lonza Group Continues To Leverage Biopharma’s Optimization Push (OTCMKTS:LZAGY) - Seeking Alpha
生物技术与制药领域的最新动态
Lonza Group Continues To Leverage Biopharma’s Optimization Push (OTCMKTS:LZAGY) - Seeking Alpha
'We don't stop': How a new owner is turning around a former Genentech site - The Business Journals
Lonza Sets Date for 2026 Ordinary General Meeting - TipRanks
Lonza’s Capsules Sale Talks Are Nearing The Finish Line - Finimize
Narrow-Moat Lonza's Long-Term Outlook Driven by Strong Outsourced Drug Manufacturing Demand - Morningstar
Switzerland’s Lonza edges closer to sale of its capsule and health ingredients business - 93.3 The Drive
Lonza still intends to sell its capsules and health ingredients business
Lonza still intends to sell its capsules and health ingredients business - Endpoints News
Earnings call transcript: Lonza reports strong 2025 results, stock dips - Investing.com
Lonza Sees Steady 2026 Growth After A Strong 2025 - Finimize
Switzerland's Lonza edges closer to sale of its capsule and health ingredients business - Reuters
Lonza delivers strong profitable growth in 2025 - The Pharma Letter
Contract drug manufacturer Lonza forecasts slower sales growth for 2026 - Reuters
Contract drug manufacturer Lonza forecasts slower sales growth for 2026 - wkzo.com
Lonza forecasts 2026 sales growth of 11-12% for core CDMO business - MSN
Lonza Sales Grow on New Contract Momentum - The Wall Street Journal
Lonza Sales Grow on New Contract Momentum - The Wall Street Journal
Lonza Sales Grow on New Contract Momentum - The Wall Street Journal
Lonza Sales Grow on New Contract Momentum - The Wall Street Journal
Lonza Sales Grow on New Contract Momentum - The Wall Street Journal